A Dose Escalation Phase 1 Study Evaluating the Safety and Pharmacokinetics of an Inhaled COVID-19 Inhibitor Delcetravir in Healthy Subjects
Clinical trial NCT05453279 · UNKNOWN
Trial details
- NCT number
- NCT05453279
- Sponsor
- Esfam Biotech Pty Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2022-11-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.